天美传媒

Ophthalmic genetics; Medical genetics; Inherited ocular disorders; Microphthalmia; Congenital cataracts; Optic neuropathy

Introduction

Inherited eye diseases encompass a diverse group of genetic disorders that pose diagnostic and management challenges. The integration of genetic testing and personalized medicine has revolutionized the field of ophthalmology. This article presents the design and outcomes of a novel multidisciplinary ophthalmic genetics clinic, which aims to provide comprehensive evaluation, genetic counseling, and tailored management strategies for patients with inherited eye disorders.

The primary objective of this research article is to describe the design and workflow of a multidisciplinary ophthalmic genetics clinic [1]. Additionally, it aims to evaluate the outcomes and impact of this clinic, including improved genetic diagnosis rates, enhanced treatment planning, and patient satisfaction. The article also discusses challenges encountered and potential future directions for expanding the scope and reach of the clinic.

Overlooking ophthalmic features of genetic syndromes can be detrimental given that genetic disease is the most common cause of blindness in young children in developed countries, comprising 50% of all childhood blindness. Subsequent reports of familial nanophthalmos were noted to be caused by pathogenic variants in this same gene, and it is now known that the ocular features of CUGS are among the most penetrant and one of the most treatable features of this syndromic condition [2].

Objectives

The primary objective of this research article is to describe the design and workflow of a multidisciplinary ophthalmic genetics clinic. Additionally, it aims to evaluate the outcomes and impact of this clinic, including improved genetic diagnosis rates, enhanced treatment planning, and patient satisfaction. The article also discusses challenges encountered and potential future directions for expanding the scope and reach of the clinic.

Rationale for a multidisciplinary ophthalmic genetics clinic Inherited eye diseases often present with diverse clinical manifestations, genetic heterogeneity, and variable disease progression.

A multidisciplinary approach allows for a holistic evaluation, incorporating ophthalmic expertise, genetic knowledge, and counseling support.

Advancements in genetic testing technologies, including nextgeneration sequencing and targeted gene panels, have revolutionized the field of ophthalmic genetics [3]. A multidisciplinary clinic provides the necessary infrastructure for efficient genetic testing, result interpretation, and integration into patient care.

Need for collaborative care

Inherited eye diseases have implications beyond ophthalmology, necessitating collaboration between ophthalmologists, geneticists, genetic counselors, and other healthcare professionals. A multidisciplinary clinic facilitates seamless communication, coordination, and integration of care for patients and families.

Clinic design and workflow

The multidisciplinary ophthalmic genetics clinic consists of a core team of ophthalmologists, geneticists, genetic counselors, nurses, and administrative staff. Each member plays a vital role in the evaluation, counseling, and management of patients [4].

Patients with suspected or diagnosed inherited eye diseases are referred to the clinic by ophthalmologists, primary care physicians, or geneticists. Appointments are scheduled to allow for comprehensive evaluations and appropriate genetic testing. Patients undergo a detailed clinical evaluation, including a thorough ophthalmic examination, family history assessment, and review of medical records. Specialized imaging, functional testing, and electrophysiological studies may be performed as necessary.

Genetic counselors play a crucial role in providing patients and families with comprehensive information about the genetic testing process, potential outcomes, and implications for inheritance patterns, prognosis, and treatment options. Informed consent is obtained before genetic testing [5]. Genetic testing is tailored to the specific clinical presentation and suspicion of inherited eye disease. Results are interpreted in conjunction with clinical findings, family history, and available literature. Genetic variants are classified according to established guidelines.

Based on the genetic diagnosis and clinical findings, personalized treatment strategies are developed, taking into account available therapeutic options, prognosis, and patient preferences. Long-term follow-up and monitoring are coordinated within the clinic.

Outcomes and impact

The multidisciplinary approach of the clinic enhances the diagnostic yield by integrating clinical expertise with genetic testing. Accurate genetic diagnoses enable precise treatment planning and genetic counseling for patients and families [6]. With a genetic diagnosis, treatment strategies can be tailored to the specific underlying genetic mutation or condition. Precision medicine approaches, such as gene therapy or targeted therapies, can be considered for eligible patients. The collaborative nature of the clinic, coupled with comprehensive evaluations and personalized care, contributes to improved patient satisfaction and experience. Patients appreciate the holistic approach, continuity of care, and access to expert opinions. The multidisciplinary clinic ensures long-term follow-up and monitoring of patients with inherited eye diseases. This allows for the timely identification of disease progression, adaptation of treatment strategies, and provision of supportive care [7].

The clinic provides a fertile ground for research collaborations, enabling the collection of clinical data, genetic information, and long-term outcomes. It also serves as a valuable educational resource, fostering knowledge exchange among healthcare professionals and training future generations of specialists [8].

Challenges and mitigation strategies

The clinic acknowledges the limitations of genetic testing, including variant interpretation, detection of novel variants, and genetic heterogeneity [9]. Regular review of literature, participation in external quality assurance programs, and interdisciplinary discussions help mitigate these challenges. The clinic adheres to ethical principles, ensuring informed consent, privacy protection, and appropriate use of genetic information. Clear communication, genetic counseling, and ongoing support help address ethical dilemmas and concerns.

The cost of genetic testing and multidisciplinary care can pose financial challenges for patients. The clinic explores insurance coverage options, advocates for reimbursement, and seeks opportunities for cost-sharing or research funding to mitigate financial burdens [10].

Conclusion

The multidisciplinary ophthalmic genetics clinic provides an integrated and comprehensive approach to the evaluation, diagnosis, and management of patients with inherited eye diseases. By combining the expertise of various healthcare professionals, it enhances genetic diagnosis rates, optimizes treatment strategies, and improves patient outcomes.

The clinic benefits patients by providing accurate diagnoses, personalized treatment plans, and ongoing support. Healthcare professionals benefit from interdisciplinary collaboration, education opportunities, and research advancements. The clinic also contributes to the broader field of ophthalmic genetics through data sharing, research collaborations, and advocacy efforts.

1. World Health Organization.
2. Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, et al. (2013) Vision Loss Expert Group. . Lancet Glob Health.1:339-349.

, ,

3. Resnikoff S, Pascolini D, Etyaale D (2004) . Bull World Health Organ.82:844–851

, ,

4. Thapa SS, Thapa R, Paudyal I (2013)  BMC Ophthalmol 13:9.

, ,

5. Hatef E, Fotouhi A, Hadhemi H, Mohammad K, Jalali KH (2008) . Retina 28: 755-762.

, ,

6. Nirmalan PK, Katz J, Robin A (2004) . Arch Ophthalmol 122:581–586.

, ,

7. Rai BB, Morley MG, Bernstein PS, Maddess T (2020) . BMC Ophthalmol.20:51.

, ,

8. Chauhan A, Chaudhary KP, Rajput GC (2014) . Int Eye Sci 14:2114–2118.
9. Saunier V, Merle BMJ, Delyfer MN (2018) Incidence of and risk factors associated with age-related macular degeneration: four-year follow-up from the ALIENOR study. JAMA Ophthalmol 136:473-481

, ,

10. Hallak JA, de Sisternes L, Osborne A, Yaspan B, Rubin DL, et al.(2019) . JAMA Ophthalmol.137:738-744

, ,